Contents of this document
- Impact of higher sales¥1,165 million
- Impact of higher cost ratio¥-67 million
- Impact of changes in sales mix¥-141 million
- Increase in selling expenses¥-185 million
- Increase in personnel expenses¥-308 million
- Increase in advertising expenses¥-525 million
- Other¥-282 million
- DS division structureFigures150-person structure
- Bottled water business revenue growthFigures+30% year on year
- Expand the DS division to a 150-person structure
- Consolidate and launch ステムセル's Singapore business from the fiscal year ending March 2027
- Change the material used for gallon bottles in the bottled water business
- Expanding investment in human capital
- Strengthen IR activities and invest in new businesses through M&A
- Increase in group headcount from the previous fiscal year-end42 PeopleYear on year against the same period last year+42 people
- Actual ROE8.5 %
- Actual PBR1.34 times
- DOE basis4 %
- Water Healthcare BusinessNet Sales21,135Year on year against the same period last year+8.0%
- Medical-related businessNet Sales3,024Year on year against the same period last year+4.4%
- Total water ionizer salesNet Sales9,242Year on year against the same period last year+1.8%
- CartridgesNet Sales5,836Year on year against the same period last year+4.2%
- PT. SUPER WAHANA TEHNO (bottled water)Net Sales4,785Year on year against the same period last year+29.2%
- Regenerative Medicine-Related BusinessNet Sales2,921Year on year against the same period last year+4.7%
- Electrolyzed Water Dialysis BusinessNet Sales102Year on year against the same period last year-5.6%
- Target fiscal yearFiscal year ending March 2027Net Sales¥27.0 billion
- Target fiscal yearFiscal year ending March 2028Net Sales¥31 billion
- ROETarget value10% or higherActual value8.5%
- DOETarget value4% targetActual value4.0%
- Cost of capitalTarget and assumptionsPerformance consistently exceeding 8.0%
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | Fiscal year ending March 2026 |
| Net Sales | ¥24,159 million (YoY +7.5%) |
| Operating profit | ¥2,940 million (YoY -10.5%) |
| Ordinary income | ¥3,147 million (YoY -11.0%) |
| Net income | ¥2,030 million (YoY -9.4%) |
| Gross Profit Margin | 67.9% |
| Operating profit margin | 12.2% |
| Selling, general and administrative expenses | ¥13,452 million |
| Full-year earnings forecast | Net Sales ¥27,000 million / Operating profit ¥3,300 million / Ordinary income ¥3,500 million / Profit attributable to owners of the parent ¥2,200 million |
| Segment results | Segment Water Healthcare Business / Net Sales ¥21,135 million / Year on year against the same period last year ¥8 million, Segment Medical-related business / Net Sales ¥3,024 million / Year on year against the same period last year ¥4.4 million, Segment Total water ionizer sales / Net Sales ¥9,242 million / Year on year against the same period last year ¥1.8 million, Segment Cartridges / Net Sales ¥5,836 million / Year on year against the same period last year ¥4.2 million, Segment PT. SUPER WAHANA TEHNO (bottled water) / Net Sales ¥4,785 million / Year on year against the same period last year ¥29.2 million, Segment Regenerative Medicine-Related Business / Net Sales ¥2,921 million / Year on year against the same period last year ¥4.7 million, Segment Electrolyzed Water Dialysis Business / Net Sales ¥102 million / Year on year against the same period last year ¥-5.6 million |
| Breakdown of Factors Affecting the Change | Factors Impact of higher sales / Amount ¥1,165 million, Factors Impact of higher cost ratio / Amount ¥-67 million, Factors Impact of changes in sales mix / Amount ¥-141 million, Factors Increase in selling expenses / Amount ¥-185 million, Factors Increase in personnel expenses / Amount ¥-308 million, Factors Increase in advertising expenses / Amount ¥-525 million, Factors Other / Amount ¥-282 million |
| Key KPIs | Indicator name Increase in group headcount from the previous fiscal year-end / Value 42 People / Year on year against the same period last year +42 people, Indicator name Actual ROE / Value 8.5 % / Year on year against the same period last year Not disclosed, Indicator name Actual PBR / Value 1.34 times / Year on year against the same period last year Not disclosed, Indicator name DOE basis / Value 4 % / Year on year against the same period last year Not disclosed |
| Number of employees | Number of Employees Not disclosed / Change during the period +42 people from the previous fiscal year-end |
| Assumptions Underlying the Business Outlook | Item DS division structure / Figures 150-person structure, Item Bottled water business revenue growth / Figures +30% year on year |
| Medium-term management plan targets | Target fiscal year Fiscal year ending March 2027 / Net Sales ¥27.0 billion, Target fiscal year Fiscal year ending March 2028 / Net Sales ¥31 billion |
| Financial targets | Indicator ROE / Target value 10% or higher / Actual value 8.5%, Indicator DOE / Target value 4% target / Actual value 4.0%, Indicator Cost of capital / Target and assumptions Performance consistently exceeding 8.0% |
| Annual Dividend | Annual dividend per share ¥130 (actual for the fiscal year ending March 2026, as shown in the graph) / Interim and Year-End Breakdown Not disclosed |
| Acquisition of treasury shares | Number of shares acquired 250,000 shares / Acquisition price Not disclosed / Period Not disclosed |
| New initiatives | Expand the DS division to a 150-person structure, Consolidate and launch ステムセル's Singapore business from the fiscal year ending March 2027, Change the material used for gallon bottles in the bottled water business, Expanding investment in human capital, Strengthen IR activities and invest in new businesses through M&A |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased due to the expansion of the bottled water business and other factors. On the earnings side, profit was weighed down by a lower gross profit margin resulting from the higher sales mix of the bottled water business, rising raw material prices including platinum, increased investment in human capital, and stepped-up advertising activities for the bottled water business.